Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
31 hedge funds and large institutions have $1.87M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 17 closing their positions.
25% more call options, than puts
Call options by funds: $15K | Put options by funds: $12K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
21% less funds holding
Funds holding: 39 → 31 (-8)
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
47% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 17
96% less capital invested
Capital invested by funds: $49.2M → $1.87M (-$47.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$478K |
| 2 |
Two Sigma Advisers
New York
|
+$326K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$194K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$170K |
| 5 |
Morgan Stanley
New York
|
+$93.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
-$9.75M |
| 2 |
SR
Summer Road
West Palm Beach,
Florida
|
-$6.77M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$5.31M |
| 4 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$4.11M |
| 5 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$3.32M |
CORV Hedge Fund Activity: Q4 2019 in Review
31 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q4 2019, worth a combined $1.87M — down 96% from $49.2M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of CORV and 9 opened new positions — a net loss of 8 holders — while 9 trimmed existing stakes and 5 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $478K. The largest seller was Westfield Capital Management, exiting entirely with an estimated $9.75M sold.
- 31 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q4 2019, down from 39 in Q3 2019.
- Funds reported $1.87M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q4 2019, down 96% quarter-over-quarter.
- 9 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q4 2019 and 17 closed out, a net change of -8 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q4 2019 was Virtu Financial, an estimated $478K added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q4 2019 was Westfield Capital Management, an estimated $9.75M sold.
Based on aggregated 13F filings for Q4 2019.